glp 1 chicago GLP-1 weight-loss drugs might help protect against breast cancer, study presented at ASCO meeting suggests Using GLP-1 Agonists with Biologics

Additionally, semaglutide slows gastric emptying, prolonging the sensation of fullness and reducing the frequency of hunger signals

On Monday, 24th November, Novo Nordisk published a press release, explaining that the Evoke and Evoke+ trials did not confirm superiority of semaglutide versus placebo in the reduction of progression of Alzheimers disease. Although the researchers did report significant reductions in biomarkers associated with Alzheimers, there was no reduction in disease progression in either trial

54:3427-3434 [PubMed: 16306358] 141

It doesn't predict what a specific individual will experience with a compounded formulation

Patients may notice a loss of vision in one eye upon waking in the morning